HOYA Releases Results of Three-Year MiYOSMART Spectacle Lens Follow-up Study
Tuesday, April 27 2021 | 10 h 22 min | News, Press Release, Vision Science
HOYA Vision Care announced during the European Academy of Optometrists and Optics (AOO21) the results of a three-year follow-up clinical study on...
Read More
Bausch + Lomb Announces Results from First Phase 3 Trial of NOV03
Thursday, April 15 2021 | 09 h 33 min | Dry Eye, News, Press Release
Bausch + Lomb and Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, announced statistically significant...
Read More
Gene Therapy Approach to Regenerate Damaged Optic Nerves
Wednesday, April 14 2021 | 07 h 26 min | Vision Science
Scientists from the University of Cambridge have used gene therapy to regenerate damaged optic nerves in the eyes of mice, offering hope that this...
Read More
LHON Study Finds Double the Impact
Wednesday, January 13 2021 | 10 h 58 min | Vision Science
In a surprising finding, scientists have shown that injecting a gene therapy for Leber’s Hereditary Optic Neuropathy (LHON) into one eye can...
Read More
Bausch Advances Novel Dry Eye Therapeutic to Phase 3
Tuesday, December 29 2020 | 07 h 28 min | Dry Eye, Latest News, News, Vision Science
Quebec based B+L has announced the second of two Phase 3 studies studies evaluating the investigational treatment NOV03 (perfluorohexyloctane) as a...
Read More
